1. Home
  2. SRDX vs RYAM Comparison

SRDX vs RYAM Comparison

Compare SRDX & RYAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SRDX
  • RYAM
  • Stock Information
  • Founded
  • SRDX 1979
  • RYAM 1926
  • Country
  • SRDX United States
  • RYAM United States
  • Employees
  • SRDX N/A
  • RYAM N/A
  • Industry
  • SRDX Medical/Dental Instruments
  • RYAM Paper
  • Sector
  • SRDX Health Care
  • RYAM Basic Materials
  • Exchange
  • SRDX Nasdaq
  • RYAM Nasdaq
  • Market Cap
  • SRDX 562.6M
  • RYAM 580.7M
  • IPO Year
  • SRDX 1998
  • RYAM N/A
  • Fundamental
  • Price
  • SRDX $39.70
  • RYAM $7.28
  • Analyst Decision
  • SRDX Hold
  • RYAM Buy
  • Analyst Count
  • SRDX 4
  • RYAM 1
  • Target Price
  • SRDX $43.00
  • RYAM $12.00
  • AVG Volume (30 Days)
  • SRDX 167.1K
  • RYAM 346.8K
  • Earning Date
  • SRDX 01-30-2025
  • RYAM 11-05-2024
  • Dividend Yield
  • SRDX N/A
  • RYAM N/A
  • EPS Growth
  • SRDX N/A
  • RYAM N/A
  • EPS
  • SRDX N/A
  • RYAM N/A
  • Revenue
  • SRDX $126,078,000.00
  • RYAM $1,630,290,000.00
  • Revenue This Year
  • SRDX $13.75
  • RYAM $0.95
  • Revenue Next Year
  • SRDX $13.67
  • RYAM $4.10
  • P/E Ratio
  • SRDX N/A
  • RYAM N/A
  • Revenue Growth
  • SRDX N/A
  • RYAM N/A
  • 52 Week Low
  • SRDX $25.17
  • RYAM $3.15
  • 52 Week High
  • SRDX $42.44
  • RYAM $10.28
  • Technical
  • Relative Strength Index (RSI)
  • SRDX 55.97
  • RYAM 23.52
  • Support Level
  • SRDX $39.59
  • RYAM $8.35
  • Resistance Level
  • SRDX $40.39
  • RYAM $8.62
  • Average True Range (ATR)
  • SRDX 0.34
  • RYAM 0.29
  • MACD
  • SRDX -0.04
  • RYAM -0.14
  • Stochastic Oscillator
  • SRDX 42.50
  • RYAM 4.14

About SRDX Surmodics Inc.

Surmodics Inc is a provider of surface modification and in vitro diagnostic technologies to the healthcare industry. The company's mission is to improve the treatment and detection of disease by using its technology to provide solutions to difficult medical devices and diagnostic challenges. It has two reportable segments: Medical device unit; Manufacture of performance coatings, including surface modification coating technologies and the Vitro diagnostics unit; Manufacture of chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets. Surmodics derives majority of its revenue from the Medical Device segment.

About RYAM Rayonier Advanced Materials Inc.

Rayonier Advanced Materials Inc manufactures high-purity cellulose derived from wood. Also known as cellulose specialties, the company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, High-Yield Pulp, and Corporate and Other. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of revenue from the United States.

Share on Social Networks: